Ulf Bremberg

 Ulf Bremberg
Ulf Bremberg
Chief Scientific Officer

Presentations at Drug Discovery 2015

Thu3  Sep04:00pm(30 mins)
Fragment-Based Lead Generation of Reversible Inhibitors for Lysine-Specific Demethylases

Session: Oncology Drug Targets
Room: To be announced

Profile of Ulf Bremberg

Ulf has a background in medicinal chemistry at Pharmacia/Biovitrum, after earning his PhD in organic chemistry at the Royal Institute of Technology, Sweden and a postdoc with Prof. Rebek, Scripps, La Jolla, USA. After Biovitrum, Ulf has headed up the SciLifeLab Drug Discovery and Development Lead Identification unit and founded several companies in drug discovery. Currently he is leading Beactica research programmes as CSO, with a focus on epigenetic targets.
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018